Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), CVS Health (CVS) and Tempest Therapeutics (TPST)
HSBC Downgrades Colgate-Palmolive(CL.US) to Hold Rating
Colgate-Palmolive Analyst Ratings
Argus Research Initiates Kimberly-Clark(KMB.US) With Hold Rating
Goldman Sachs Maintains Colgate-Palmolive(CL.US) With Buy Rating
RBC Capital Maintains Mondelez International(MDLZ.US) With Buy Rating, Maintains Target Price $80
J.P. Morgan Maintains Philip Morris International(PM.US) With Buy Rating, Raises Target Price to $125
Coca-Cola Price Target Raised to $70.00/Share From $65.00 by TD Cowen
Philip Morris Price Target Raised to $125.00/Share From $110.00 by JP Morgan
Coca-Cola: Strong Q2 Performance and Raised Guidance Balanced by FX Headwinds – Hold Rating Maintained
Deutsche Bank Adjusts Philip Morris International Price Target to $118 From $116, Maintains Buy Rating
Truist Raises Price Target on Coca-Cola to $70 From $65, Keeps Buy Rating
Deutsche Numis Initiates Philip Morris International(PM.US) With Buy Rating, Announces Target Price $118
Coca-Cola Price Target Raised to $73.00/Share From $70.00 by Wells Fargo
Kimberly-Clark Price Target Cut to $134.00/Share From $138.00 by Wells Fargo
Kimberly-Clark Analyst Ratings
Coca-Cola Analyst Ratings
Deutsche Numis Maintains Kimberly-Clark(KMB.US) With Hold Rating, Raises Target Price to $142
Wells Fargo Adjusts Price Target on Kimberly-Clark to $134 From $138
Goldman Sachs Adjusts Price Target on Philip Morris International to $126 From $120